Биотехнологии

Illustration of a cat in a lab with DNA linking to human and dog cancer genes for a news article on feline tumor study.

Study of nearly 500 cat tumors finds cancer-gene overlaps with humans and dogs

24 мая 2026 Сообщено ИИ Изображение, созданное ИИ Проверено фактами

A genetic analysis of 493 tumors from domestic cats collected across five countries found that feline cancers share many of the same cancer-driving genes seen in people and dogs, including frequent FBXW7 mutations in feline mammary tumors that are linked to poorer outcomes in some human breast cancers. The results were published in Science.

Engineered phages redirect vaccine immunity to eradicate tumors in mice

Researchers have used genetically modified phages to harness pre-existing vaccine immunity and destroy cancer cells in mice. The approach eradicated tumors in 44 percent of treated animals with no recurrence after a year.

Руководители предупреждают о рисках создания биологического оружия с помощью ИИ и генных технологий

24 июня 2026 Сообщено ИИ

Ведущие руководители фармацевтических и технологических компаний бьют тревогу по поводу возможного использования ИИ и генных технологий для создания биологического оружия.

Европа

HMNC Brain Health привлекла 50 миллионов долларов

Азия

Oncolys president reflects on journey to world-first cancer treatment

Африка

National Biosafety Authority outlines GMO rules in Kenya

Egypt Vaccine City investments to reach EGP 12bn by 2030

Egypt’s Vaccine City and Biotechnology project is expected to attract investments worth EGP 12bn by 2030, according to the Minister of Health and Population.

Longevity startup doses first patient in vision loss trial

9 июня 2026 Сообщено ИИ

A longevity startup has administered its first dose of a cellular rejuvenation therapy to a patient. The move follows recent FDA approval for human clinical trials of the treatment known as ER-100.

Gene-editing drug slashes bad cholesterol 62 percent in trial

An experimental therapy called VERVE-102 lowered LDL cholesterol by up to 62 percent after a single dose in an early safety study. The results come from a Phase I trial involving 35 patients with high cholesterol or early cardiovascular disease. Data were published this week in the New England Journal of Medicine.

MIT study links dietary cysteine to faster small-intestine repair in mice

21 мая 2026 Сообщено ИИ Проверено фактами

MIT researchers report that the amino acid cysteine, found in many protein-rich foods, can enhance the small intestine’s ability to regenerate after injury in mice by triggering an immune-to-stem-cell signaling cascade. The work, published in Nature, raises the possibility—still untested in people—that diet or supplementation could someday help ease some treatment-related intestinal damage during radiation or chemotherapy.

24 июня 2026, 08:50